Back to Search Start Over

A complier average causal effect analysis of the Stimulant Reduction Intervention using dosed exercise study

Authors :
Chad D. Rethorst
Thomas J. Carmody
Tracy L. Greer
Madhukar H. Trivedi
Robrina Walker
Source :
Contemporary Clinical Trials Communications, Vol 10, Iss, Pp 1-8 (2018), Contemporary Clinical Trials Communications
Publication Year :
2018
Publisher :
Elsevier BV, 2018.

Abstract

Objective: Exercise is a promising treatment for substance use disorders, yet an intention-to-treat analysis of a large, multi-site study found no reduction in stimulant use for exercise versus health education. Exercise adherence was sub-optimal; therefore, secondary post-hoc complier average causal effects (CACE) analysis was conducted to determine the potential effectiveness of adequately dosed exercise. Method: The STimulant use Reduction Intervention using Dosed Exercise study was a randomized controlled trial comparing a 12 kcal/kg/week (KKW) exercise dose versus a health education control conducted at nine residential substance use treatment settings across the U.S. that are affiliated with the National Drug Abuse Treatment Clinical Trials Network. Participants were sedentary but medically approved for exercise, used stimulants within 30 days prior to study entry, and received a DSM-IV stimulant abuse or dependence diagnosis within the past year. A CACE analysis adjusted to include only participants with a minimum threshold of adherence (at least 8.3 KKW) and using a negative-binomial hurdle model focused on 218 participants who were 36.2% female, mean age 39.4 years (SD = 11.1), and averaged 13.0 (SD = 9.2) stimulant use days in the 30 days before residential treatment. The outcome was days of stimulant use as assessed by the self-reported TimeLine Follow Back and urine drug screen results. Results: The CACE-adjusted analysis found a significantly lower probability of relapse to stimulant use in the exercise group versus the health education group (41.0% vs. 55.7%, p

Details

ISSN :
24518654
Volume :
10
Database :
OpenAIRE
Journal :
Contemporary Clinical Trials Communications
Accession number :
edsair.doi.dedup.....4dba845c99ed25189c19ce3b888f8e8e